Adamax
Jump to navigation
Jump to search
| File:Adamax structure.png | |
| Identifiers | |
|---|---|
| E number | {{#property:P628}} |
| CompTox Dashboard (EPA) |
|
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 29: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C50H69N11O11S |
| Molar mass | 1032.23 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Adamax (Ac-MEHFPGPAG-NH2) is a synthetic peptide derivative that is a designer analogue of semax, described as semax modified with the N-terminal and C-terminal modifications found in Peptide 021. It has been identified as a designer drug in border seizures and classified as a prescription medicine in New Zealand for legal reasons.[1]
References
[edit | edit source]- ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).